Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA; Institute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata 997-0052, Japan; Graduate School of Media and Governance, Keio University, Fujisawa, Kanagawa 252-0882, Japan.
Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
Cell Rep. 2020 Mar 24;30(12):4137-4151.e6. doi: 10.1016/j.celrep.2020.02.117.
Schlafen 11 (SLFN11) was recently discovered as a cellular restriction factor against replication stress. Here, we show that SLFN11 increases chromatin accessibility genome wide, prominently at active promoters in response to replication stress induced by the checkpoint kinase 1 (CHK1) inhibitor prexasertib or the topoisomerase I (TOP1) inhibitor camptothecin. Concomitantly, SLFN11 selectively activates cellular stress response pathways by inducing the transcription of the immediate early genes (IEGs), including JUN, FOS, EGR1, NFKB2, and ATF3, together with the cell cycle arrest genes CDKN1A (p21) and GADD45. Both chromatin remodeling and IEG activation require the putative ATPase and helicase activity of SLFN11, whereas canonical extrinsic IEG activation is SLFN11 independent. SLFN11-dependent IEG activation by camptothecin is also observed across 55 non-isogenic NCI-60 cell lines. We conclude that SLFN11 acts as a global regulator of chromatin structure and an intrinsic IEG activator with the potential to engage the innate immune activation in response to replicative stress.
SLFN11 最近被发现是一种细胞限制因子,可抵抗复制应激。在这里,我们表明 SLFN11 会增加染色质的全基因组可及性,在复制应激下(由检查点激酶 1 (CHK1)抑制剂 prexasertib 或拓扑异构酶 I (TOP1)抑制剂喜树碱诱导),在活跃的启动子处尤为显著。同时,SLFN11 通过诱导即时早期基因 (IEG)的转录,选择性地激活细胞应激反应途径,包括 JUN、FOS、EGR1、NFKB2 和 ATF3,以及细胞周期阻滞基因 CDKN1A (p21) 和 GADD45。染色质重塑和 IEG 激活都需要 SLFN11 的假定 ATP 酶和解旋酶活性,而经典的外在 IEG 激活则与 SLFN11 无关。喜树碱诱导的 SLFN11 依赖性 IEG 激活也在 55 个非同源 NCI-60 细胞系中观察到。我们的结论是,SLFN11 作为染色质结构的全局调节剂和内在 IEG 激活剂发挥作用,具有在复制应激下参与固有免疫激活的潜力。